Ottestad L - Search Results

1

[Breast cancer patients' assessment of waiting time before radiotherapy].

Brustugun OT, Nome O, Bruland S ØS, Ottestad L, Lilleby W. Brustugun OT, et al. Among authors: ottestad l. Tidsskr Nor Laegeforen. 2003 Jun 12;123(12):1685-6. Tidsskr Nor Laegeforen. 2003. PMID: 12821991 Norwegian.

2

[Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].

Schjølseth SA, Hagen T, Ottestad L, Jakobsen E. Schjølseth SA, et al. Among authors: ottestad l. Tidsskr Nor Laegeforen. 1995 Nov 10;115(27):3371-3. Tidsskr Nor Laegeforen. 1995. PMID: 7491579 Norwegian.

3

Radiation-induced effects on gene expression: an in vivo study on breast cancer.

Helland A, Johnsen H, Frøyland C, Landmark HB, Saetersdal AB, Holmen MM, Gjertsen T, Nesland JM, Ottestad W, Jeffrey SS, Ottestad LO, Rodningen OK, Sherlock G, Børresen-Dale AL. Helland A, et al. Radiother Oncol. 2006 Aug;80(2):230-5. doi: 10.1016/j.radonc.2006.07.007. Epub 2006 Aug 4. Radiother Oncol. 2006. PMID: 16890317

4

Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial.

Engebraaten O, Edvardsen H, Løkkevik E, Naume B, Kristensen V, Ottestad L, Natarajan V. Engebraaten O, et al. Among authors: ottestad l. ISRN Oncol. 2012;2012:176789. doi: 10.5402/2012/176789. Epub 2012 May 14. ISRN Oncol. 2012. PMID: 22666610 Free PMC article.

5

Screening for germ line TP53 mutations in breast cancer patients.

Børresen AL, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sørensen B, Hovig E, Malkin D, et al. Børresen AL, et al. Among authors: ottestad l. Cancer Res. 1992 Jun 1;52(11):3234-6. Cancer Res. 1992. PMID: 1591732

6

[Determination of estrogen receptors in fine-needle aspirates from breast carcinoma. A description of a method].

Lilleng R, Hagmar B, Myrtvedt M, Ottestad L. Lilleng R, et al. Among authors: ottestad l. Tidsskr Nor Laegeforen. 1989 May 30;109(15):1630-2. Tidsskr Nor Laegeforen. 1989. PMID: 2741142 Norwegian. No abstract available.

7

Drug sensitivity testing of human breast cancer.

Tveit KM, Ottestad L. Tveit KM, et al. Among authors: ottestad l. Acta Oncol. 1990;29(3):335-8. doi: 10.3109/02841869009090010. Acta Oncol. 1990. PMID: 2194534 Review.

8

The effect of pre-morbid height and weight on the survival of breast cancer patients.

Tretli S, Haldorsen T, Ottestad L. Tretli S, et al. Among authors: ottestad l. Br J Cancer. 1990 Aug;62(2):299-303. doi: 10.1038/bjc.1990.282. Br J Cancer. 1990. PMID: 2386747 Free PMC article.

9

Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM.

Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL. Laake K, et al. Among authors: ottestad l. Genes Chromosomes Cancer. 1997 Mar;18(3):175-80. Genes Chromosomes Cancer. 1997. PMID: 9071570

10

DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival.

Fleischer T, Klajic J, Aure MR, Louhimo R, Pladsen AV, Ottestad L, Touleimat N, Laakso M, Halvorsen AR, Grenaker Alnæs GI, Riis ML, Helland Å, Hautaniemi S, Lønning PE, Naume B, Børresen-Dale AL, Tost J, Kristensen VN. Fleischer T, et al. Among authors: ottestad l. Oncotarget. 2017 Jan 3;8(1):1074-1082. doi: 10.18632/oncotarget.13718. Oncotarget. 2017. PMID: 27911866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

45 results

Search Page